Charles Eifrig, MD
Retina Specialist · Laguna Hills, CANPI 1306812979
Payments from drug & device makers
Across 437 payments — averaging $686.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$170K
- Alcon Research LLC$51K
- Alcon$39K
- Regeneron$13K
- Carl Zeiss Meditec, Inc.$10K
- AbbVie$8K
- plus $10K from 22 others
What the payments were for
- Consulting fees$111,36740%
- Speaking & faculty fees$123,52044%
- Travel & lodging$30,64011%
- Food & beverage$16,1496%
- Education$1310%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 198 | $169,746 |
| Alcon Research LLC | 25 | $50,530 |
| Alcon | 75 | $38,984 |
| Regeneron | 3 | $12,529 |
| Carl Zeiss Meditec, Inc. | 3 | $10,420 |
| AbbVie(2 entities) | 28 | $7,784 |
| Beaver-visitec International, Inc. | 1 | $2,100 |
| Hexal AG | 1 | $2,100 |
| Ocular Therapeutix, Inc. | 1 | $1,500 |
| Regeneron Healthcare Solutions, Inc. | 38 | $1,455 |
| Apellis Pharmaceuticals, Inc. | 9 | $757 |
| Astellas Pharma US Inc | 14 | $406 |
| Eyepoint US, Inc. | 6 | $325 |
| Alimera Sciences, Inc. | 6 | $211 |
| Dutch Ophthalmic, USA | 2 | $193 |
| Genentech, Inc. | 3 | $163 |
| Coherus Oncology, Inc. | 5 | $126 |
| NEW World Medical,inc. | 1 | $124 |
| Bausch & Lomb Americas Inc. | 3 | $65 |
| Novartis | 3 | $58 |
| Astellas Pharma Global Development | 3 | $54 |
| Sandoz | 2 | $45 |
| Biogen | 2 | $35 |
| Pacira Therapeutics, Inc. | 1 | $30 |
| Heidelberg Engineering, Inc. | 1 | $27 |
| Carl Zeiss Meditec USA, Inc. | 1 | $21 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Harrow Eye, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$125,461
- Lucentis$37,440
- Constellation$24,001
- SUSVIMO$11,175
- Clarus 700$10,350
- OZURDEX$6,454
- NGENUITY$5,170
- Centurion$3,500
- EYLEA HD$2,762
- Unity$2,293
- Luxor$1,400
- Syfovre$503
- EYLEA$247
- YUTIQ$242
- EVA Ophthalmic Surgical System$173
- Ahmed Glaucoma Valve$124
- Kahook Dual Blade$124
- Iluvien$111
How this compares
$299,826 in reported general payments places this provider in the 80th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 21 | $7,135 |
| Prednisolone Acetate | 130 | $3,732 |
| Ketorolac Tromethamine | 157 | $3,141 |
| Difluprednate | 18 | $1,936 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 63 | $1,895 |
| Atropine Sulfate | 13 | $326 |
| Timolol Maleate | 11 | $109 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Laguna Hills
- Dante PieramiciSanta Barbara$15.1M
- Margaret ChangSacramento$13.2M
- Hani Salehi-HadHuntington Beach$12.2M
- Payam AminiPasadena$9.9M
- Joel PearlmanSacramento$8.3M
- Dilsher DhootSanta Barbara$8.2M
- Ashkan PirouzFullerton$6.9M
- Roger GoldbergWalnut Creek$5M
- Sean AdreanFullerton$2.9M
- Nathan SteinleSanta Barbara$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.